0.778

0.42% -0.0033

After Hours: .77 -0.008 -1.03%

Pasithea Therapeutics Corp (KTTA)

Overview News Price History Financials Discussions Forecast

Pasithea Therapeutics Corp stock is traded at $0.778, with a volume of 59,070. It is down -0.42% in the last 24 hours and down -7.13% over the past month. Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Previous Close:

$0.7813

Open:

$0.799

24h Volume:

59,070

Relative Volume:

0.32

Market Cap:

$17.96M

Revenue:

Net Income/Loss:

$-13.49M

P/E Ratio:

-0.1531

EPS:

-5.0823

Net Cash Flow:

$-12.26M

1W Performance:

-0.52%

1M Performance:

-7.13%

6M Performance:

+6.96%

1Y Performance:

-43.62%

1-Day Range:

$0.7652

$0.8132

1-Week Range:

$0.751

$0.8132

52-Week Range:

$0.281

$3.79

Pasithea Therapeutics Corp Stock (KTTA) Company Profile

Name

Pasithea Therapeutics Corp

Sector

Healthcare (1113)

Industry

Biotechnology (623)

Phone

(702) 514-4174

Address

1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH

Employee

Twitter

Next Earnings Date

2026-03-30

Latest SEC Filings

KTTA's Discussions on Twitter

Compare KTTA vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KTTA Pasithea Therapeutics Corp	0.778	18.04M	0	-13.49M	-12.26M	-5.0823
VRTX Vertex Pharmaceuticals Inc	453.74	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	756.73	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.16	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	692.83	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	147.60	31.97B	606.42M	-1.28B	-997.58M	-6.403

Pasithea Therapeutics Corp Stock (KTTA) Latest News

05:29 AM

Highs Report: What is the long term forecast for Pasithea Therapeutics Corp stockQuarterly Market Summary & Low Drawdown Investment Ideas - baoquankhu1.vn

05:29 AM

Mar 25, 2026

Can Pasithea Therapeutics Corp sustain earnings growth2026 Chart Watch & High Yield Stock Recommendations - baoquankhu1.vn

Mar 25, 2026

Positive Signs As Multiple Insiders Buy Pasithea Therapeutics Stock - simplywall.st

Mar 25, 2026

Mar 24, 2026

Winners Losers: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly priced2026 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn

Mar 24, 2026

KTTA Stock Price, Quote & Chart | PASITHEA THERAPEUTICS CORP (NASDAQ:KTTA) - ChartMill

Mar 24, 2026

Mar 21, 2026

Panic Selling: Whats the beta of Pasithea Therapeutics Corp Equity Warrant stockGDP Growth & Weekly High Momentum Picks - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Pasithea Therapeutics Corp expected to post a loss of 18 cents a shareEarnings Preview - TradingView

Mar 20, 2026

Mar 19, 2026

Layoff Watch: What is the next catalyst for Pasithea Therapeutics Corp Equity WarrantQuarterly Market Review & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Mar 19, 2026

Mar 18, 2026

Gains Report: Is Pasithea Therapeutics Corp Equity Warrant attractive for institutional investors2026 Earnings Surprises & Consistent Return Investment Signals - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Analyst Calls: How does Pasithea Therapeutics Corp correlate with Nasdaq2026 Momentum & Weekly Watchlist for Consistent Profits - baoquankhu1.vn

Mar 17, 2026

Aug EndMonth: What is Pasithea Therapeutics Corp Equity Warrants revenue forecast2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn

Mar 17, 2026

Mar 11, 2026

Smart Money: Whats the beta of Pasithea Therapeutics Corp stock2026 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Mar 11, 2026

Mar 09, 2026

Pullback Watch: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly priced2026 Price Action Summary & Stepwise Trade Signal Guides - baoquankhu1.vn

Mar 09, 2026

Mar 07, 2026

Fund Flows: Is Pasithea Therapeutics Corp Equity Warrant impacted by rising rates2026 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn

Mar 07, 2026

Will Pasithea Therapeutics Corp. Equity Warrant stock recover faster than market2026 Patterns & Entry Point Strategy Guides - Naître et grandir

Mar 07, 2026

Mar 06, 2026

RSI Check: What is Pasithea Therapeutics Corp Equity Warrants revenue forecastJuly 2025 Rallies & Expert Approved Momentum Ideas - baoquankhu1.vn

Mar 06, 2026

Mar 03, 2026

Earnings Recap: Whats the beta of Pasithea Therapeutics Corp stockMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn

Mar 03, 2026

Fed Watch: Whats the beta of Pasithea Therapeutics Corp Equity Warrant stockIPO Watch & Fast Entry High Yield Tips - baoquankhu1.vn

Mar 03, 2026

Mar 02, 2026

Certain Options of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 3-MAR-2026. - marketscreener.com

Mar 02, 2026

Certain Common Stock of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 3-MAR-2026. - marketscreener.com

Mar 02, 2026

Feb 28, 2026

KTTA PE Ratio & Valuation, Is KTTA Overvalued - Intellectia AI

Feb 28, 2026

KTTA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026

Feb 27, 2026